ST Pharm

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 13, 2019	Avidity Biosciences	$100.0M Series C	Roderick Wong	Alethea Capital, Alexandria Venture Investments, Boxer Capital, Brace Pharma Capital, Cormorant Asset Management, CureDuchenne Ventures, EcoR1 Capital, Eli Lilly and Company, Logos Capital, Partner Fund Management, Perceptive Advisors, Takeda Ventures